Literature DB >> 1988206

Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum.

J Kropf1, A M Gressner, W Tittor.   

Abstract

We earlier observed a positive correlation between portal venous pressure (PVP) and the concentration of laminin in serum. Here we investigated whether the diagnostic efficacy could be improved by considering additional analytes and application of multivariate statistical analysis. In 102 patients with fibrotic liver disease of various etiologies we measured PVP as the gradient of the wedged and free hepatic venous pressures and determined the concentrations of hyaluronic acid and laminin in serum. Regression coefficients established by logistic regression in this group were subsequently used to predict portal hypertension (PVP greater than mmHg) in an independent group of 45 patients. By comparison with the known PVP, we obtained a sensitivity of 0.83 (confidence interval: 0.63-0.93) and a specificity of 0.82 (0.61-0.93) for diagnosis of portal hypertension by means of the concentrations of hyaluronic acid and laminin in serum. Application of the model is suggested as a tool for pre-screening and monitoring patients to be subjected to assessment of portal hypertension.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988206

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.

Authors:  Axel-M Gressner; Chun-Fang Gao; Olav-A Gressner
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 2.  Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Woo Kyoung Jeong; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

4.  Serum laminin in malaria.

Authors:  C Wenisch; W Graninger; C Viravan; S Looareesuwan; B Parschalk; W Wernsdorfer
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

5.  Noninvasive evaluation of portal hypertension: emerging tools and techniques.

Authors:  V K Snowdon; N Guha; J A Fallowfield
Journal:  Int J Hepatol       Date:  2012-06-07

Review 6.  Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality.

Authors:  O A Gressner; R Weiskirchen; A M Gressner
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

7.  Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.

Authors:  D J Leeming; M A Karsdal; I Byrjalsen; F Bendtsen; J Trebicka; M J Nielsen; C Christiansen; S Møller; A Krag
Journal:  Aliment Pharmacol Ther       Date:  2013-09-15       Impact factor: 8.171

8.  Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study.

Authors:  Xingshun Qi; Hongyu Li; Jiang Chen; Chunlian Xia; Ying Peng; Junna Dai; Yue Hou; Han Deng; Jing Li; Xiaozhong Guo
Journal:  Gastroenterol Res Pract       Date:  2015-12-06       Impact factor: 2.260

9.  Dynamic Hyaluronan drives liver endothelial cells towards angiogenesis.

Authors:  Sampa Ghose; Subhrajit Biswas; Kasturi Datta; Rakesh K Tyagi
Journal:  BMC Cancer       Date:  2018-06-11       Impact factor: 4.430

10.  Noninvasive Evaluation of Portal Hypertension Using a Supervised Learning Technique.

Authors:  Mindaugas Marozas; Romanas Zykus; Andrius Sakalauskas; Limas Kupčinskas; Arūnas Lukoševičius
Journal:  J Healthc Eng       Date:  2017-10-12       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.